Shashank K R on The Use of Lumbrokinase from Eudrilus eugeniae
Shashank K R, Assistant Lecturer at Yuvaraja’s College, shared on LinkedIn:
”Cardiovascular diseases driven by thrombosis remain a major global health challenge.
Our study focuses on the isolation, purification, and biochemical characterization of lumbrikinase from Eudrilus eugeniae, demonstrating strong fibrinolytic activity, favorable kinetics, and stability under physiological conditions—highlighting its potential as a safer and effective thrombolytic agent for cardiovascular therapeutics.”
Read the full article here.
Article: Exploring the Fibrinolytic and Biochemical characteristics of Lumbrokinase enzyme from Eudrilus eugeniae for Therapeutic Use
Authors: Shashank K R, Malliah Mahadevaswamy
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 3, 2026, 18:24Alexandros Rampotas: Targeting Mutant CALR With Precision CAR-T Therapy
-
Jul 3, 2026, 18:08Ram Khandelwal: Why AI Is Transforming Patient Education and the Future of Healthcare
-
Jul 3, 2026, 17:55Miguel Bronchud: Why Congenital Neutropenia Is Often Missed
-
Jul 3, 2026, 17:35Patrick Rensen: Celebrating 25 Years in Endocrinology at Leiden University Medical Center
-
Jul 3, 2026, 16:54Alberico Catapano: The Role of Triglyceride Variability and the AIFA Reimbursement Gap
-
Jul 3, 2026, 16:44Barbara Lovrencic: Amplifying the Patient Voice at the EMA – Shaping the Future of ITP Care
-
Jul 3, 2026, 16:34Andrea Bisso: Exploring the T Cell Engagers in Autoimmune Diseases
-
Jul 3, 2026, 16:24Rizwan Ullah: Managing Severe Tirofiban-Induced Thrombocytopenia
-
Jul 3, 2026, 16:17Neeraj Jain: Maharashtra Strengthens Hemoglobinopathies and Thalassemia Care Through Integrated Public Health Collaboration